Glabellar Botulinum Toxin Injections for the Treatment of Geriatric Depression

NCT03833063 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER_GOV

Sponsor class

Stopped recruitment difficulties due to COVID19

Conditions

Major Depressive Disorder
Major Depressive Episode
Treatment Resistant Depression

Interventions

DRUG: botulinum toxin A
DRUG: Placebos

Sponsor

Helse Stavanger HF